{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:19:18Z","timestamp":1792189158914,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:00:00Z","timestamp":1609977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Deanship of Scientific Research, King Khalid University","award":["G.R.P2\/78-40"],"award-info":[{"award-number":["G.R.P2\/78-40"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Pneumocystis pneumonia (PCP) is a fatal infectious disease caused by\n                      <jats:italic>Pneumocystis jirovecii<\/jats:italic>\n                      (PJP). The major factor relevant to morbidity and mortality seems to be the host inflammatory reaction. The objective of this study was to evaluate the role of IL-2, IL-4, IL-10, and IL-13 cytokine mRNA expression among suspected\n                      <jats:italic>P. jirovecii<\/jats:italic>\n                      infection.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a cross-sectional analytical study undertaken in Aseer region, Saudi Arabia. One hundred suspected PCP cases and 100 healthy controls were included in the study. Basic clinical manifestations, radiological findings, microbiological and immunological findings were extracted from the hospital records from January 2019 to August 2019, Pneumocystis detection was done by immune-fluorescent staining (IFAT, Gomorimethanamine silver staining (GMSS), Giemsa staining, Toluidine blue O (TBO), and Pneumocystis RT-PCR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Increased more than 5 fold, 3 fold, 4 fold, and 7 fold of IL-2, IL-4, IL-10, and IL-13 mRNA expression were observed in PCP cases compared to controls. Higher expression of IL-2 mRNA was connected with crept, wheezing and chest X-ray findings like central perihilar infiltrate, patchy infiltrate, consolidation, hilar lymphadenopathy, pneumothorax, pleural effusion which showed higher expression compared to counterpart (\n                      <jats:italic>p<\/jats:italic>\n                      &lt;\u20090.0001). Higher expression of IL-4 mRNA was found to be significantly associated with weight loss (\n                      <jats:italic>p<\/jats:italic>\n                      =0.002), dyspnea (\n                      <jats:italic>p<\/jats:italic>\n                      =0.003), crept (\n                      <jats:italic>p<\/jats:italic>\n                      =0.01), and chest X-ray findings (\n                      <jats:italic>p<\/jats:italic>\n                      &lt;\u20090.0001). Significantly increased expression of IL-10 mRNA was observed to be associated with weight loss, dyspnea, night sweats, wheezing, and different findings of chest X-ray compared to their counterparts, whereas, IL-13 mRNA was observed in cases with fever. Suspected cases of PCP confirmed positive by IFTA with higher IL-2, IL-4, and IL-10 mRNA expression compared to negative cases. RT-PCR confirmed PCP cases had significantly higher expression of IL-2, IL-4, and IL-10 as well as IL-13 mRNA compared to negative cases. Positive detected cases by GMSS showed higher IL-2, IL-10 mRNA expression, while Giemsa showed only higher IL-4 mRNA expression compared to negative cases.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      Confirmed cases of\n                      <jats:italic>P. jirovecii<\/jats:italic>\n                      showed higher IL-2, IL-4, IL-10, and IL-13 mRNA expression comparatively to negative cases. Increased expression of cytokines may be indicative of infection severity and could help in patients\u2019 management.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-020-05729-6","type":"journal-article","created":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T11:03:46Z","timestamp":1610017426000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Increased mRNA expression of key cytokines among suspected cases of Pneumocystis jirovecii infection"],"prefix":"10.1186","volume":"21","author":[{"given":"Mohammad Y.","family":"Alshahrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alfaifi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesfer","family":"Al Shahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz S.","family":"Alshahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali G.","family":"Alkhathami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayed A.","family":"Dera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shadma","family":"Wahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirza M. A.","family":"Beg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Hakamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed E.","family":"Hamid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,7]]},"reference":[{"key":"5729_CR1","volume-title":"A real-time PCR-based diagnostic test for organisms in respiratory tract infection. Polymerase chain reactions for biomedical applications","author":"T Hirama","year":"2016","unstructured":"Hirama T. A real-time PCR-based diagnostic test for organisms in respiratory tract infection. Polymerase chain reactions for biomedical applications. IntechOpen Limited, London, UK: Intech Open Science; 2016."},{"issue":"4","key":"5729_CR2","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1183\/09031936.00095811","volume":"39","author":"K M\u00fchlethaler","year":"2012","unstructured":"M\u00fchlethaler K, B\u00f6gli-Stuber K, Wasmer S, von Garnier C, Dumont P, Rauch A, M\u00fchlemann K, Garzoni C. Quantitative PCR to diagnose Pneumocystis pneumonia in immunocompromised non-HIV patients. Eur Respir J. 2012;39(4):971\u20138.","journal-title":"Eur Respir J"},{"issue":"24","key":"5729_CR3","doi-asserted-by":"publisher","first-page":"2487","DOI":"10.1056\/NEJMra032588","volume":"350","author":"CF Thomas Jr","year":"2004","unstructured":"Thomas CF Jr, Limper AH. Pneumocystis pneumonia. N Engl J Med. 2004;350(24):2487\u201398.","journal-title":"N Engl J Med"},{"issue":"4","key":"5729_CR4","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2169\/internalmedicine.49.2871","volume":"49","author":"S Tasaka","year":"2010","unstructured":"Tasaka S, Tokuda H, Sakai F, Fujii T, Tateda K, Johkoh T, Ohmagari N, Ohta H, Araoka H, Kikuchi Y, et al. Comparison of clinical and radiological features of pneumocystis pneumonia between malignancy cases and acquired immunodeficiency syndrome cases: a multicenter study. Intern Med. 2010;49(4):273\u201381.","journal-title":"Intern Med"},{"issue":"9","key":"5729_CR5","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1172\/JCI6688","volume":"104","author":"TW Wright","year":"1999","unstructured":"Wright TW, Gigliotti F, Finkelstein JN, McBride JT, An CL, Harmsen AG. Immune-mediated inflammation directly impairs pulmonary function, contributing to the pathogenesis of Pneumocystis carinii pneumonia. J Clin Invest. 1999;104(9):1307\u201317.","journal-title":"J Clin Invest"},{"issue":"4","key":"5729_CR6","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/S1369-5274(03)00089-4","volume":"6","author":"GB Huffnagle","year":"2003","unstructured":"Huffnagle GB, Deepe GS. Innate and adaptive determinants of host susceptibility to medically important fungi. Curr Opin Microbiol. 2003;6(4):344\u201350.","journal-title":"Curr Opin Microbiol"},{"issue":"3","key":"5729_CR7","doi-asserted-by":"publisher","first-page":"235","DOI":"10.2174\/1389201003378924","volume":"1","author":"A Mencacci","year":"2000","unstructured":"Mencacci A, Cenci E, Bacci A, Montagnoli C, Bistoni F, Romani L. Cytokines in candidiasis and aspergillosis. Curr Pharm Biotechnol. 2000;1(3):235\u201351.","journal-title":"Curr Pharm Biotechnol"},{"issue":"1","key":"5729_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nri1255","volume":"4","author":"L Romani","year":"2004","unstructured":"Romani L. Immunity to fungal infections. Nat Rev Immunol. 2004;4(1):1\u201323.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"5729_CR9","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1586\/eci.12.22","volume":"8","author":"I Raphael","year":"2012","unstructured":"Raphael I, Forsthuber TG. Stability of T-cell lineages in autoimmune diseases. Expert Rev Clin Immunol. 2012;8(4):299\u2013301.","journal-title":"Expert Rev Clin Immunol"},{"key":"5729_CR10","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/9783527692156.ch24","volume-title":"Inflammation: From Molecular and Cellular Mechanisms to the Clinic","author":"WF Carson","year":"2017","unstructured":"Carson WF, Kunkel SL. Type I and II cytokine superfamilies in inflammatory responses. In: Cavaillon JM, Singer M, editors. Inflammation: From Molecular and Cellular Mechanisms to the Clinic. Weinheim: Wiley-VCH Verlag GmbH & Co. KGaA; 2017. p. 587\u2013618."},{"issue":"11","key":"5729_CR11","doi-asserted-by":"publisher","first-page":"6298","DOI":"10.4049\/jimmunol.169.11.6298","volume":"169","author":"C Montagnoli","year":"2002","unstructured":"Montagnoli C, Bacci A, Bozza S, Gaziano R, Mosci P, Sharpe AH, Romani L. B7\/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J Immunol. 2002;169(11):6298\u2013308.","journal-title":"J Immunol"},{"issue":"5","key":"5729_CR12","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.4049\/jimmunol.0802978","volume":"182","author":"R Spolski","year":"2009","unstructured":"Spolski R, Kim HP, Zhu W, Levy DE, Leonard WJ. IL-21 mediates suppressive effects via its induction of IL-10. J Immunol. 2009;182(5):2859\u201367.","journal-title":"J Immunol"},{"issue":"6","key":"5729_CR13","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.4049\/jimmunol.174.6.3484","volume":"174","author":"S Cao","year":"2005","unstructured":"Cao S, Liu J, Song L, Ma X. The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages. J Immunol. 2005;174(6):3484\u201392.","journal-title":"J Immunol"},{"issue":"6","key":"5729_CR14","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1038\/ni.2617","volume":"14","author":"P Licona-Limon","year":"2013","unstructured":"Licona-Limon P, Kim LK, Palm NW, Flavell RA. TH2, allergy and group 2 innate lymphoid cells. Nat Immunol. 2013;14(6):536\u201342.","journal-title":"Nat Immunol"},{"issue":"1","key":"5729_CR15","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/imr.12037","volume":"252","author":"G Vahedi","year":"2013","unstructured":"Vahedi G, CP A, Hand TW, Laurence A, Kanno Y, O'Shea JJ, Hirahara K. Helper T-cell identity and evolution of differential transcriptomes and epigenomes. Immunol Rev. 2013;252(1):24\u201340.","journal-title":"Immunol Rev"},{"key":"5729_CR16","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1146\/annurev.immunol.17.1.701","volume":"17","author":"K Nelms","year":"1999","unstructured":"Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol. 1999;17:701\u201338.","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"5729_CR17","doi-asserted-by":"publisher","first-page":"4538","DOI":"10.4049\/jimmunol.136.12.4538","volume":"136","author":"RL Coffman","year":"1986","unstructured":"Coffman RL, Ohara J, Bond MW, Carty J, Zlotnik A, Paul WE. B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J Immunol. 1986;136(12):4538\u201341.","journal-title":"J Immunol"},{"issue":"7","key":"5729_CR18","doi-asserted-by":"publisher","first-page":"509","DOI":"10.26719\/2016.22.7.509","volume":"22","author":"A Abubakar","year":"2016","unstructured":"Abubakar A, Malik M, Pebody RG, Elkholy AA, Khan W, Bellos A, Mala P. Burden of acute respiratory disease of epidemic and pandemic potential in the WHO Eastern Mediterranean Region: a literature review. East Mediterr Health J. 2016;22(7):509\u201322.","journal-title":"East Mediterr Health J"},{"issue":"6","key":"5729_CR19","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1016\/j.sjbs.2020.04.032","volume":"27","author":"MY Alshahrani","year":"2020","unstructured":"Alshahrani MY, Alfaifi M, Ahmad I, Alkhathami AG, Hakami AR, Ahmad H, Alshehri OM, Dhakad MS. Pneumocystis Jirovecii detection and comparison of multiple diagnostic methods with quantitative real-time PCR in patients with respiratory symptoms. Saudi J Biol Sci. 2020;27(6):1423\u20137.","journal-title":"Saudi J Biol Sci"},{"issue":"4","key":"5729_CR20","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212Delta Delta C(T)) method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"8","key":"5729_CR21","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1086\/339548","volume":"34","author":"KA Sepkowitz","year":"2002","unstructured":"Sepkowitz KA. Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin Infect Dis. 2002;34(8):1098\u2013107.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"5729_CR22","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.3109\/13693786.2010.484027","volume":"48","author":"X Iriart","year":"2010","unstructured":"Iriart X, Witkowski B, Courtais C, Abbes S, Tkaczuk J, Courtade M, Cassaing S, Fillaux J, Blancher A, Magnaval JF, et al. Cellular and cytokine changes in the alveolar environment among immunocompromised patients during Pneumocystis jirovecii infection. Med Mycol. 2010;48(8):1075\u201387.","journal-title":"Med Mycol"},{"issue":"4","key":"5729_CR23","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1165\/ajrcmb.17.4.2851","volume":"17","author":"TW Wright","year":"1997","unstructured":"Wright TW, Johnston CJ, Harmsen AG, Finkelstein JN. Analysis of cytokine mRNA profiles in the lungs of Pneumocystis carinii-infected mice. Am J Respir Cell Mol Biol. 1997;17(4):491\u2013500.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"3","key":"5729_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.7326\/0003-4819-111-3-223","volume":"111","author":"H Masur","year":"1989","unstructured":"Masur H, Ognibene FP, Yarchoan R, Shelhamer JH, Baird BF, Travis W, Suffredini AF, Deyton L, Kovacs JA, Falloon J, et al. CD4 counts as predictors of opportunistic pneumonias in human immunodeficiency virus (HIV) infection. Ann Intern Med. 1989;111(3):223\u201331.","journal-title":"Ann Intern Med"},{"issue":"2","key":"5729_CR25","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.4049\/jimmunol.170.2.1002","volume":"170","author":"MH Qureshi","year":"2003","unstructured":"Qureshi MH, Harmsen AG, Garvy BA. IL-10 modulates host responses and lung damage induced by Pneumocystis carinii infection. J Immunol. 2003;170(2):1002\u20139.","journal-title":"J Immunol"},{"key":"5729_CR26","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2334-2-28","volume":"2","author":"J Helweg-Larsen","year":"2002","unstructured":"Helweg-Larsen J, Jensen JS, Dohn B, Benfield TL, Lundgren B. Detection of Pneumocystis DNA in samples from patients suspected of bacterial pneumonia--a case-control study. BMC Infect Dis. 2002;2:28.","journal-title":"BMC Infect Dis"},{"issue":"1","key":"5729_CR27","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1164\/ajrccm.155.1.9001290","volume":"155","author":"JD Stansell","year":"1997","unstructured":"Stansell JD, Osmond DH, Charlebois E, LaVange L, Wallace JM, Alexander BV, Glassroth J, Kvale PA, Rosen MJ, Reichman LB, et al. Predictors of Pneumocystis carinii pneumonia in HIV-infected persons. Pulmonary complications of HIV infection study group. Am J Respir Crit Care Med. 1997;155(1):60\u20136.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"5729_CR28","doi-asserted-by":"publisher","first-page":"ofx193","DOI":"10.1093\/ofid\/ofx193","volume":"4","author":"L Doyle","year":"2017","unstructured":"Doyle L, Vogel S, Procop GW. Pneumocystis PCR: It Is Time to Make PCR the Test of Choice. Open Forum Infect Dis. 2017;4(4):ofx193.","journal-title":"Open Forum Infect Dis"},{"issue":"1","key":"5729_CR29","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/15412550701817656","volume":"5","author":"A Morris","year":"2008","unstructured":"Morris A, Sciurba FC, Norris KA. Pneumocystis: a novel pathogen in chronic obstructive pulmonary disease? Copd. 2008;5(1):43\u201351.","journal-title":"Copd"},{"issue":"9","key":"5729_CR30","doi-asserted-by":"publisher","first-page":"e73099","DOI":"10.1371\/journal.pone.0073099","volume":"8","author":"LC Fan","year":"2013","unstructured":"Fan LC, Lu HW, Cheng KB, Li HP, Xu JF. Evaluation of PCR in bronchoalveolar lavage fluid for diagnosis of Pneumocystis jirovecii pneumonia: a bivariate meta-analysis and systematic review. PLoS One. 2013;8(9):e73099.","journal-title":"PLoS One"},{"issue":"12","key":"5729_CR31","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1093\/infdis\/jit099","volume":"207","author":"JN Jarvis","year":"2013","unstructured":"Jarvis JN, Casazza JP, Stone HH, Meintjes G, Lawn SD, Levitz SM, Harrison TS, Koup RA. The phenotype of the Cryptococcus-specific CD4+ memory T-cell response is associated with disease severity and outcome in HIV-associated cryptococcal meningitis. J Infect Dis. 2013;207(12):1817\u201328.","journal-title":"J Infect Dis"},{"issue":"3","key":"5729_CR32","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1128\/IAI.00274-06","volume":"75","author":"FL Wormley Jr","year":"2007","unstructured":"Wormley FL Jr, Perfect JR, Steele C, Cox GM. Protection against cryptococcosis by using a murine gamma interferon-producing Cryptococcus neoformans strain. Infect Immun. 2007;75(3):1453\u201362.","journal-title":"Infect Immun"},{"issue":"2","key":"5729_CR33","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.4049\/jimmunol.174.2.1027","volume":"174","author":"Y Hernandez","year":"2005","unstructured":"Hernandez Y, Arora S, Erb-Downward JR, McDonald RA, Toews GB, Huffnagle GB. Distinct roles for IL-4 and IL-10 in regulating T2 immunity during allergic bronchopulmonary mycosis. J Immunol. 2005;174(2):1027\u201336.","journal-title":"J Immunol"},{"issue":"6","key":"5729_CR34","doi-asserted-by":"publisher","first-page":"2489","DOI":"10.2353\/ajpath.2009.090530","volume":"175","author":"Y Zhang","year":"2009","unstructured":"Zhang Y, Wang F, Tompkins KC, McNamara A, Jain AV, Moore BB, Toews GB, Huffnagle GB, Olszewski MA. Robust Th1 and Th17 immunity supports pulmonary clearance but cannot prevent systemic dissemination of highly virulent Cryptococcus neoformans H99. Am J Pathol. 2009;175(6):2489\u2013500.","journal-title":"Am J Pathol"},{"issue":"6","key":"5729_CR35","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1086\/314493","volume":"178","author":"E Cenci","year":"1998","unstructured":"Cenci E, Mencacci A, FdO C, Del Sero G, Mosci P, Montagnoli C, Bacci A, Romani L. Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis. J Infect Dis. 1998;178(6):1750\u201360.","journal-title":"J Infect Dis"},{"issue":"1","key":"5729_CR36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.jaci.2016.02.031","volume":"139","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, Biagini Myers JM, Brandt EB, Ryan PH, Lindsey M, Mintz-Cole RA, Reponen T, Vesper SJ, Forde F, Ruff B, et al. \u03b2-Glucan exacerbates allergic asthma independent of fungal sensitization and promotes steroid-resistant T(H)2\/T(H)17 responses. J Allergy Clin Immunol. 2017;139(1):54\u201365 e58.","journal-title":"J Allergy Clin Immunol"},{"issue":"12","key":"5729_CR37","doi-asserted-by":"publisher","first-page":"a019828","DOI":"10.1101\/cshperspect.a019828","volume":"4","author":"F Gigliotti","year":"2014","unstructured":"Gigliotti F, Limper AH, Wright T. Pneumocystis. Cold Spring Harbor Perspect Med. 2014;4(12):a019828.","journal-title":"Cold Spring Harbor Perspect Med"},{"issue":"7","key":"5729_CR38","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1128\/JCM.42.7.3333-3335.2004","volume":"42","author":"GW Procop","year":"2004","unstructured":"Procop GW, Haddad S, Quinn J, Wilson ML, Henshaw NG, Reller LB, Artymyshyn RL, Katanik MT, Weinstein MP. Detection of Pneumocystis jiroveci in respiratory specimens by four staining methods. J Clin Microbiol. 2004;42(7):3333\u20135.","journal-title":"J Clin Microbiol"},{"key":"5729_CR39","doi-asserted-by":"crossref","unstructured":"Otieno-Odhiambo P, Wasserman S, Hoving JC. The Contribution of Host Cells to Pneumocystis Immunity: An Update. Pathogens. 2019;8(2).","DOI":"10.3390\/pathogens8020052"},{"issue":"3","key":"5729_CR40","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1080\/14740338.2019.1577817","volume":"18","author":"G Murdaca","year":"2019","unstructured":"Murdaca G, Negrini S, Pellecchio M, Greco M, Schiavi C, Giusti F, Puppo F. Update upon the infection risk in patients receiving TNF alpha inhibitors. Expert Opin Drug Saf. 2019;18(3):219\u201329.","journal-title":"Expert Opin Drug Saf"},{"issue":"7","key":"5729_CR41","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1093\/rheumatology\/kew200","volume":"55","author":"ES Bruce","year":"2016","unstructured":"Bruce ES, Kearsley-Fleet L, Watson KD, Symmons DP, Hyrich KL. Risk of Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis treated with inhibitors of tumour necrosis factor alpha: results from the British Society for Rheumatology biologics register for rheumatoid arthritis. Rheumatology. 2016;55(7):1336\u20137.","journal-title":"Rheumatology"},{"issue":"7","key":"5729_CR42","doi-asserted-by":"publisher","first-page":"704","DOI":"10.3109\/13693786.2013.772689","volume":"51","author":"CW Chou","year":"2013","unstructured":"Chou CW, Lin FC, Tsai HC, Chang SC. The importance of pro-inflammatory and anti-inflammatory cytokines in Pneumocystis jirovecii pneumonia. Med Mycol. 2013;51(7):704\u201312.","journal-title":"Med Mycol"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05729-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05729-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05729-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T15:05:54Z","timestamp":1674831954000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05729-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,7]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["5729"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05729-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-49177\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-49177\/v2","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-49177\/v3","asserted-by":"object"}]},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,7]]},"assertion":[{"value":"30 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The Research Ethics Committee Deanship of Scientific Research, King Khalid University, Abha, Kingdom of Saudi Arabia, approved the present research work with reference approval number (ECM-2019-73). Upon this approval, data were collected directly from patient charts. Written consent was obtained from all study participants.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests. None of the authors have financial and nonfinancial conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"28"}}